CHARLES RIVER LABORATORIES (CRL)
US1598641074 - Common Stock
| 2023 (2023-12-30) | 2022 (2022-12-31) | 2021 (2021-12-25) | 2020 (2020-12-26) | 2019 (2019-12-28) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 480.37M | 492.61M | 398.84M | 365.30M | 254.10M | |||
| Depreciation Amortization | 314.12M | 303.87M | 265.54M | 234.90M | 198.10M | |||
| Income Taxes - Deferred | -50.90M | -35.88M | -24.01M | -100.00K | -21.90M | |||
| Change In Working Capital | -102.38M | -152.55M | 42.94M | -26.30M | 6.20M | |||
| Interest Paid | 132.10M | 100.75M | 70.78M | 72.50M | 67.80M | |||
| Taxes Paid | 90.37M | 75.91M | 75.44M | 60.10M | 54.10M | |||
| Other non cash items | 42.69M | 11.60M | 77.49M | -27.20M | 44.50M | |||
| OPERATING CASH FLOW | 683.90M | 619.64M | 760.80M | 546.60M | 480.90M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -318.53M | -324.73M | -228.77M | -166.60M | -140.50M | |||
| Other Investing Activity | -244.63M | -283.19M | -1.21B | -435.00M | -541.00M | |||
| INVESTING CASH FLOW | -563.15M | -607.92M | -1.44B | -601.50M | -681.50M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -75.32M | 19.79M | 708.24M | 30.60M | 233.90M | |||
| Stock Issued/Repurchased | 1.44M | -13.54M | 4.95M | 22.60M | 16.50M | |||
| Other Financing Activity | -11.64M | -48.65M | -40.58M | -5.90M | -18.40M | |||
| FINANCING CASH FLOW | -85.52M | -42.40M | 672.60M | 47.20M | 231.90M | |||
| Exchange Rate Effect | 8.04M | 25.58M | 17.73M | 800.00K | 11.40M | |||
| CHANGE IN CASH | 43.27M | -5.10M | 13.19M | -6.90M | 42.70M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 683.90M | 619.64M | 760.80M | 546.60M | 480.90M | |||
| Capital Expenditure | -318.53M | -324.73M | -228.77M | -166.60M | -140.50M | |||
| FREE CASH FLOW | 365.37M | 294.91M | 532.03M | 380.00M | 340.40M | |||
All data in USD